IN2012DN00282A - - Google Patents

Info

Publication number
IN2012DN00282A
IN2012DN00282A IN282DEN2012A IN2012DN00282A IN 2012DN00282 A IN2012DN00282 A IN 2012DN00282A IN 282DEN2012 A IN282DEN2012 A IN 282DEN2012A IN 2012DN00282 A IN2012DN00282 A IN 2012DN00282A
Authority
IN
India
Prior art keywords
breast
compositions
infants
fed infants
nutritional supplement
Prior art date
Application number
Other languages
English (en)
Inventor
Degonda Gabriela Bergonzelli
Isabelle Bureau-Franz
Clara Lucia Garcia-Rodenas
Corinne Magliola
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41259077&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2012DN00282(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of IN2012DN00282A publication Critical patent/IN2012DN00282A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/48—Moist feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Birds (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pediatric Medicine (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
IN282DEN2012 2009-07-31 2010-07-28 IN2012DN00282A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09166969 2009-07-31
PCT/EP2010/060973 WO2011012655A1 (fr) 2009-07-31 2010-07-28 Composition nutritionnelle pour nourrissons ou animaux de compagnie allaités comprenant des probiotiques et des nutriments sélectionnés

Publications (1)

Publication Number Publication Date
IN2012DN00282A true IN2012DN00282A (fr) 2015-05-08

Family

ID=41259077

Family Applications (1)

Application Number Title Priority Date Filing Date
IN282DEN2012 IN2012DN00282A (fr) 2009-07-31 2010-07-28

Country Status (14)

Country Link
US (1) US20120121562A1 (fr)
EP (1) EP2459202A1 (fr)
CN (1) CN102481323A (fr)
AU (1) AU2010277582A1 (fr)
BR (1) BR112012002223A2 (fr)
CA (1) CA2767960A1 (fr)
CL (1) CL2012000234A1 (fr)
IN (1) IN2012DN00282A (fr)
MX (1) MX2012001362A (fr)
RU (1) RU2012107695A (fr)
SG (1) SG177541A1 (fr)
TW (1) TW201117818A (fr)
WO (1) WO2011012655A1 (fr)
ZA (1) ZA201201471B (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2822497C (fr) 2010-12-31 2020-07-28 Abbott Laboratories Procedes de reduction de l'incidence du stress oxydatif utilisant des oligosaccharides du lait de femme, de la vitamine c et des agents anti-inflammatoires
CN110051676A (zh) 2010-12-31 2019-07-26 雅培制药有限公司 用于调节炎症的人乳寡糖
NZ611807A (en) 2010-12-31 2015-02-27 Abbott Lab Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
EP3473257A1 (fr) 2010-12-31 2019-04-24 Abbott Laboratories Procédés d'utilisation d'oligosaccharides du lait humain pour améliorer la santé respiratoire des voies aériennes
MX355780B (es) 2010-12-31 2018-04-30 Abbott Lab Fórmula pediátrica sintética para estimular células nerviosas entéricas en el tracto gastrointestinal.
EP3510873A1 (fr) 2010-12-31 2019-07-17 Abbott Laboratories Compositions nutritionnelles comprenant des oligosaccharides et nucléotides du lait humain et leurs utilisations pour traiter et/ou prévenir l'infection virale entérique
MX352040B (es) 2010-12-31 2017-11-07 Abbott Lab Formulaciones nutricionales que incluyen los oligosacaridos de leche humana y los acidos grasos poliinsaturados de cadena larga y usos de las mismas.
CN102106463B (zh) * 2011-01-31 2012-12-05 杨永浩 一种微生物饲料添加剂及其制备方法
CN104126749A (zh) * 2011-02-10 2014-11-05 雀巢产品技术援助有限公司 使用人乳中发现的特定量的寡糖的组合调节双歧杆菌属的生长
ITMI20111488A1 (it) * 2011-08-03 2013-02-04 Gnosis Spa Formulazioni comprendenti saccharomyces boulardii e superossido dismutasi (sod) per controllare l'obesita'
BR112014004772A2 (pt) 2011-08-29 2017-03-21 Abbott Lab oligossacarídeos do leite humano para evitar danos e/ou promover a cura do trato gastrointestinal
US20140271562A1 (en) * 2011-10-18 2014-09-18 Nestec S.A. Composition for use in brain growth and/or cognitive and/or psychomotor development
WO2013057062A1 (fr) * 2011-10-18 2013-04-25 Nestec S.A. Composition destinée à être utilisée pour favoriser l'angiogenèse intestinale et l'absorption de substances nutritives et la tolérance à l'alimentation entérale et/ou pour la prévention et/ou le traitement d'une inflammation intestinale et/ou pour la récupération après lésion et chirurgie intestinales
KR101166798B1 (ko) * 2011-12-19 2012-07-26 김대현 락토바실러스 애시도필러스 엘비의 사균을 포함하는 알레르기 질환의 치료 또는 예방용 의약 조성물
UA118339C2 (uk) * 2012-09-03 2019-01-10 Біогайа Аб Бактеріальний штам lactobacillus gasseri для лікування порушення моторики кишечнику (варіанти)
US9987306B2 (en) 2012-10-15 2018-06-05 University Of Florida Research Foundation, Inc. Materials and methods for prevention and treatment of diarrhea and inflammation in the gastrointestinal tract
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
MX2016012427A (es) 2014-03-26 2017-04-27 Abbott Lab Suplemento alimenticio en polvo.
WO2015176229A1 (fr) * 2014-05-20 2015-11-26 Nestle (China) Ltd. Compositions nutritionnelles de synthèse spécifiques au mode d'accouchement et systèmes nutritionnels les comprenant
AU2016227596B2 (en) * 2015-03-05 2020-01-16 Société des Produits Nestlé S.A. Compositions for use in improving stool consistency or frequency in infants or young children
EP3294308A4 (fr) 2015-05-14 2019-03-06 University of Puerto Rico Procédé de restauration du microbiote de nouveau-nés
CN105030843A (zh) * 2015-06-18 2015-11-11 陈英扬 罗伊氏乳杆菌滴剂及其制备方法
BR112018000786B1 (pt) * 2015-08-31 2022-06-14 Société des Produits Nestlé S.A. Uso de b. longum atcc baa-999 na preparação de composição comestível para tratar depressão
AU2016374155A1 (en) * 2015-12-14 2018-04-19 Société des Produits Nestlé S.A. Nutritional composition and infant formula for promoting myelination of the brain
US11564667B2 (en) 2015-12-28 2023-01-31 New York University Device and method of restoring microbiota of newborns
WO2017151540A1 (fr) 2016-02-29 2017-09-08 Abbott Laboratories Complément alimentaire en poudre
KR101938865B1 (ko) * 2016-11-03 2019-01-16 주식회사 쎌바이오텍 골 질환, 비만 및 지질 관련 대사성 질환의 예방 또는 치료용 조성물
MX2019011334A (es) * 2017-05-24 2019-10-30 Nestle Sa Composicion que comprende oligofructosa (of) para usar en la mejora de la memoria a corto plazo y otros beneficios congnitivos.
WO2019002607A1 (fr) * 2017-06-30 2019-01-03 N.V. Nutricia Composition symbiotique pour la prévention de troubles
WO2019038668A1 (fr) 2017-08-21 2019-02-28 Glycom A/S Composition synthétique pour réduire les symptômes d'allergie
CN108823125A (zh) * 2018-06-13 2018-11-16 山东巴元生物科技有限公司 一种治疗睡眠障碍益生菌制剂的生产方法及应用
WO2020033708A1 (fr) * 2018-08-08 2020-02-13 Mars, Incorporated Produits alimentaires pour animaux de compagnie comprenant des oligosaccharides et procédés d'utilisation
JP7407195B2 (ja) * 2018-12-21 2023-12-28 ソシエテ・デ・プロデュイ・ネスレ・エス・アー アレルギー性疾患の治療のためのプロバイオティクスの組み合わせ
WO2020161113A1 (fr) * 2019-02-04 2020-08-13 N.V. Nutricia Préparation pour nourrissons fermentée avec des oligosaccharides non digestibles pour l'amélioration du sommeil
KR102188765B1 (ko) * 2019-06-12 2020-12-08 정옥숙 애완동물용 동결건조파우더 및 이의 제조방법
EP4065146A1 (fr) * 2019-11-29 2022-10-05 Société des Produits Nestlé S.A. Compositions et procédés avec un probiotique et un nutriment et/ou un minéral pour la prévention ou le traitement de la mastite
CN112868800A (zh) * 2019-11-29 2021-06-01 内蒙古伊利实业集团股份有限公司 含母乳低聚糖提高免疫力的婴幼儿配方奶粉及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3936799C1 (fr) * 1989-11-04 1991-01-10 Deutsche Atochem Werke Gmbh, 5300 Bonn, De
FR2714574B1 (fr) * 1993-12-31 1996-03-15 Inst Rech Biolog Sa Nouveaux suppléments alimentaires pour la nutrition des très jeunes enfants.
CA2458936A1 (fr) * 2001-08-31 2003-03-13 Nutricopia, Inc. Dessert glace nutritionnel et procedes de fabrication associes
ATE433674T1 (de) * 2003-06-23 2009-07-15 Nestec Sa Säuglingsnährpräparat oder folgemilch
WO2004112508A1 (fr) * 2003-06-23 2004-12-29 Nestec S.A. Preparation pour nourrisson ou lait de suite
WO2005035557A2 (fr) * 2003-10-14 2005-04-21 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin Adenylcyclase intervenant dans le traitement et/ou la prophylaxie d'une maladie a mediation immunitaire
US7862808B2 (en) * 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
CN101128129A (zh) * 2005-02-28 2008-02-20 纽崔西亚公司 具有益生菌的营养组合物
US20060251634A1 (en) * 2005-05-06 2006-11-09 Ho-Jin Kang Method of improving immune function in mammals using lactobacillus strains with certain lipids
US20070059297A1 (en) * 2005-08-04 2007-03-15 Nestec, S.A. Methods and compositions for improving visual acuity
PT1940248E (pt) * 2005-10-05 2010-01-26 Nestec Sa Utilização de uma composição nutricional para promoção do crescimento acelerado
CN101410121B (zh) * 2006-03-29 2012-02-29 雀巢产品技术援助有限公司 含益生菌的膳食补充剂
US7374924B2 (en) 2006-06-05 2008-05-20 Biogaia Ab Use of selected lactic acid bacteria for reducing infantile colic
NL1033521C2 (nl) * 2007-03-08 2008-09-09 Friesland Brands Bv Kindervoedingen met geoptimaliseerde aminozuursamenstelling.
EP1974743A1 (fr) * 2007-03-28 2008-10-01 Nestec S.A. Probiotiques pour l'amélioration du microbiote intestinal
EP1974734A1 (fr) * 2007-03-28 2008-10-01 Nestec S.A. Probiotiques pour la réduction du risque d'obésité
US20090118228A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
BRPI0820802A2 (pt) * 2007-12-17 2015-06-16 Univ Florida Materiais e métodos para tratamento de proliferação vascular ocular patológica
EP2344148B2 (fr) * 2008-09-19 2024-05-08 Société des Produits Nestlé S.A. Soutien nutritionnel pour prévenir ou modérer la paralysie de la moelle osseuse pendant un traitement anticancéreux

Also Published As

Publication number Publication date
MX2012001362A (es) 2012-02-22
BR112012002223A2 (pt) 2016-06-07
CN102481323A (zh) 2012-05-30
WO2011012655A1 (fr) 2011-02-03
AU2010277582A1 (en) 2012-02-02
RU2012107695A (ru) 2013-09-10
EP2459202A1 (fr) 2012-06-06
CL2012000234A1 (es) 2012-09-28
SG177541A1 (en) 2012-02-28
CA2767960A1 (fr) 2011-02-03
ZA201201471B (en) 2014-08-27
US20120121562A1 (en) 2012-05-17
TW201117818A (en) 2011-06-01

Similar Documents

Publication Publication Date Title
IN2012DN00282A (fr)
MY164674A (en) Fucosyllactose as breast milk identical non-digestible oligosaccharide with new functional benefit
MX2022004262A (es) Composiciones de cannabinoides para usarse en mejorar la salud, metodos de fabricacion y uso de las mismas.
PH12017502350A1 (en) Nutritional compositions with 2fl and lnnt for use in inducing a gut microbiota close to the one of breast fed infants
MY173382A (en) Infant feeding formulas comprising probiotic micro-organisms
MX2013005338A (es) Gama de formulas nutricionales adaptadas a la edad con probioticos.
IN2012DN00713A (fr)
IN2014CN04773A (fr)
MY161548A (en) Nutritional supplements for 50+individuals for improving vitality, immunity, eye and bone health
MX369699B (es) Ácido graso del aceite de bogol para uso en suplementos y composiciones de tratamiento y piensos para animales.
PH12017502182A1 (en) Nutritional compositions and infant formulas comprising bifidobacterium animalis ssp. lactis and optionally a mix of oligosaccharides for inducing a gut microbiota close to the one of breast fed infants
MX2013005406A (es) Composicion nutricional adaptada a la edad con grasas animales y grasas vegetales.
MY175195A (en) Nutritional compositions
MX2013012136A (es) Composiciones que comprenden un antimetabolito de glucosa y selenio.
PH12018500988A1 (en) Nutritional compositions and infant formulas to promote myelination in the brain
SG149718A1 (en) Cordyceps extract as a dietary supplement and uses thereof
MY174494A (en) Method for inhibiting pathogens using a nutritional composition
PH12018500953A1 (en) Nutritional compositions and infant formulas to promote myelination in the brain
MX2013006741A (es) Composicones a base de arcilla y polen de abeja, su proceso de preparacion y su uso nutricional y terapeutico.
PH12018500924A1 (en) Nutritional compositions and infant formulas to promote myelination in the brain
PT2477503E (pt) Processo de preparação de um produto lácteo pasteurizado e fermentado, suplementado com cálcio e vitamina d
PH12018500890A1 (en) Nutritional compositions and infant formulas to promote myelination in the brain
MX2018006296A (es) Composiciones nutritivas y formulas infantiles para promover la mielinizacion en el cerebro.
CN105454817A (zh) 一种补钙食品
UA47261U (ru) Способ улучшения племенной ценности быков мясных пород